Prescribing guidelines for severe Pseudomonas infections

被引：61

作者：

Giamarellou, H ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Sismanoglio Gen Hosp, Dept Internal Med 4, Athens 15126, Greece

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 49卷 / 02期

关键词：

D O I：

10.1093/jac/49.2.229

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：229 / 233

页数：5

共 46 条

[1]

*AM LUNG ASS AM TH, 1995, AM J RESP CRIT CARE, V153, P1711

[2] COMBINATIONS OF ANTIBIOTICS AGAINST PSEUDOMONAS-AERUGINOSA [J].

BALTCH, AL ;

SMITH, RP .

AMERICAN JOURNAL OF MEDICINE, 1985, 79 (1A) :8-16

[3] Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae [J].

Blondeau, JM ;

Zhao, XL ;

Hansen, G ;

Drlica, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :433-438

[4] PSEUDOMONAS BACTEREMIA - RETROSPECTIVE ANALYSIS OF 410 EPISODES [J].

BODEY, GP ;

JADEJA, L ;

ELTING, L .

ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (09) :1621-1629

[5]

Brewer Susan Crouch, 1996, Chest, V109, P1019, DOI 10.1378/chest.109.4.1019

[6] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents [J].

Carmeli, Y ;

Troillet, N ;

Eliopoulos, GM ;

Samore, MH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1379-1382

[7] EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA [J].

COHEN, ML .

SCIENCE, 1992, 257 (5073) :1050-1055

[8] Appearance of IMP-1 metallo-β-lactamase in Europe [J].

Cornaglia, G ;

Riccio, ML ;

Mazzariol, A ;

Lauretti, L ;

Fontana, R ;

Rossolini, GM .

LANCET, 1999, 353 (9156) :899-900

[9] Pharmacodynamics, a tool for a better use of antibiotics? [J].

Crokaert, F .

INTENSIVE CARE MEDICINE, 2001, 27 (02) :340-343

[10]

Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640

← 1 2 3 4 5 →